Cargando…

S10.3d Yeast Microbiome in patients with inflammatory bowel disease (IBD)

S10.3 THE MYCOBIOME CHARACTERIZATION: FUTURE PERSPECTIVES OR JUST A TREND?, SEPTEMBER 24, 2022, 10:30 AM - 12:00 PM: OBJECTIVE: The intestinal microbiota plays major roles in host-protective functions and inflammatory bowel diseases (IBDs). Although some data suggest a role of the yeast microbiota...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vaezi, Afsane, Fakhim, Hamed, Jabbari, Mehrdad, Nasri, Elahe, Azar, Mohammad Reza Hosseini, Diba, Kambiz, Badali, Hamid
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Oral Presentations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511524/ http://dx.doi.org/10.1093/mmy/myac072.S10.3d

Ejemplares similares

P244 Catheter-associated blood stream infections due to Wickerhamiella pararugosa in a patient with acute myeloid leukemia: Review of lit eratures
por: Nasri, Elahe, et al.
Publicado: (2022)

P398 COVID-19-associated pulmonary aspergillosis: Species distribution and susceptibility profiles
por: Fakhim, Hamed, et al.
Publicado: (2022)

P032 Efficacy of novel azole compounds (ATTAF-1 and ATTAF-2) against Candida albicans in a murine model of invasive Candidiasis
por: Badali, Hamid, et al.
Publicado: (2022)

Fatal Invasive Pulmonary Aspergillosis in COVID-19 Patient with Acute Myeloid Leukemia in Iran
por: Nasri, Elahe, et al.
Publicado: (2020)

Frequency and Geographic Distribution of CARD9 Mutations in Patients With Severe Fungal Infections
por: Vaezi, Afsane, et al.
Publicado: (2018)

Rapid and Low-Cost Culture-Based Method for Diagnosis of Mucormycosis Using a Mouse Model
por: Vaezi, Afsane, et al.
Publicado: (2020)

Efficacy of Hydroxychloroquine in Pre-exposure Severe Acute Respiratory Syndrome Coronavirus 2 Prophylaxis among High-Risk HealthCare Workers: A Multicenter Study
por: Nasri, Elahe, et al.
Publicado: (2023)

Asymptomatic carriers of coronavirus disease 2019 among healthcare workers in Isfahan, Iran
por: Fakhim, Hamed, et al.
Publicado: (2021)

Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome
por: Khan, Israr, et al.
Publicado: (2019)

P183 Monitoring of candida colonization in the respiratory tract of COVID-19 cases
por: Diba, Kambiz, et al.
Publicado: (2022)

P182 Mucormycosis in Northwest Iranian cases with a history of delta COVID-19, a brief report
por: Diba, Kambiz, et al.
Publicado: (2022)

OC.02.1 SAFETY OF COVID-19 VACCINE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: DATA OF A NATIONAL STUDY (ESCAPE-IBD)
por: Todeschini, A., et al.
Publicado: (2022)

P103 Role of biofilm production in recalcitrant tinea
por: Gangar, Seema, et al.
Publicado: (2022)

P026 Antifungal activity of a novel triazole and comparators against a large collection of identified Aspergillus isolates
por: Abbasi, Kiana, et al.
Publicado: (2022)

Low-Cost Tetraplex PCR for the Global Spreading Multi-Drug Resistant Fungus, Candida auris and Its Phylogenetic Relatives
por: Arastehfar, Amir, et al.
Publicado: (2018)

The correlation between viral shedding duration and blood biomarkers in COVID-19-infected patients
por: Sadeghi, Somayeh, et al.
Publicado: (2022)

Influence of Genetics, Immunity and the Microbiome on the Prognosis of Inflammatory Bowel Disease (IBD Prognosis Study): the protocol for a Copenhagen IBD Inception Cohort Study
por: Attauabi, Mohamed, et al.
Publicado: (2022)

The Seroprevalence and Seropositivity of SARS-CoV-2 among Healthcare Workers during the Third Pandemic Wave
por: Vaezi, Atefeh, et al.
Publicado: (2022)

Bridges to excellence quality indicators in inflammatory bowel disease (IBD): differences between IBD and non-IBD gastroenterologists
por: Bilal, Mohammad, et al.
Publicado: (2017)

Intercontinental Gut Microbiome Variances in IBD
por: Mayorga, Luis, et al.
Publicado: (2022)

Editorial: Microbiome in IBD: From Composition to Therapy
por: Zhu, Ruixin, et al.
Publicado: (2021)

Future of Endoscopy in Inflammatory Bowel Diseases (IBDs)
por: Agrawal, Laksh S, et al.
Publicado: (2022)

Helminth Lessons in Inflammatory Bowel Diseases (IBD)
por: Atagozli, Tyler, et al.
Publicado: (2023)

Fusarium proliferatum-induced chronic lip ulcer: successful treatment with itraconazole: a case report
por: Mohaghegh, Fatemeh, et al.
Publicado: (2022)

Nutritional Assessment in Inflammatory Bowel Disease (IBD)—Development of the Groningen IBD Nutritional Questionnaires (GINQ)
por: Peters, Vera, et al.
Publicado: (2019)

Endoscopic stricturotomy in the treatment of anastomotic strictures in inflammatory bowel disease (IBD) and non-IBD patients
por: Zhang, Long-Juan, et al.
Publicado: (2019)

Improving the care of inflammatory bowel disease (IBD) patients: perspectives and strategies for IBD center management
por: Park, Jihye, et al.
Publicado: (2021)

Not All that Strictures Is IBD: Gastric Heterotopia Leading to Perforation and Small Bowel Obstruction Mimicking IBD
por: Ralbovsky, Amariel, et al.
Publicado: (2022)

CCR9+ and CD103+ tolerogenic dendritic cell populations in food allergy patients undergoing oral immunotherapy
por: Garcia, Marco, et al.
Publicado: (2011)

Molecular and microscopy detection of Pneumocystis jirovecii in hospitalized patients during the COVID-19 pandemic
por: Matouri, Roya, et al.
Publicado: (2023)

P156 Oral Candidiasis among inpatients with COVID‐19 in the North of Iran
por: Ahangarkani, Fatemeh, et al.
Publicado: (2022)

Modulation of cytokine patterns and microbiome during pregnancy in IBD
por: van der Giessen, Janine, et al.
Publicado: (2020)

Controlled drug release for inflammatory bowel disease (IBD)
por: Asha, D, et al.
Publicado: (2020)

COVID-19 Vaccination in Inflammatory Bowel Disease (IBD)
por: Kubas, Aleksandra, et al.
Publicado: (2022)

Novel Therapies and Approaches to Inflammatory Bowel Disease (IBD)
por: Furfaro, Federica, et al.
Publicado: (2022)

S10.3c Clinical studies provide new insights on the association between the microbiota and host resistance to Candida albicans intestinal colonization
por: Delavy, Margot, et al.
Publicado: (2022)

Comparison the effects and side effects of Covid-19 vaccination in patients with inflammatory bowel disease (IBD): a systematic scoping review
por: Tabesh, Elham, et al.
Publicado: (2022)

A4 PREDNISOLONE, A GLUCOCORTICOID WIDELY USED FOR TREATMENT OF IBD, ENHANCES A HUMAN INTERLEUKIN-4-ACTIVATED MACROPHAGE PHENOTYPE
por: Deshpande, R S, et al.
Publicado: (2023)

The Oral Microbiome in Pediatric IBD: A Source of Pathobionts or Biomarkers?
por: Elmaghrawy, Khalid, et al.
Publicado: (2021)

Editorial: Microbiome in IBD: From Composition to Therapy, Volume II
por: Liu, Ning-Ning, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_e20v0jfipmmp55i6skael520jc